Eliana Merle
Stock Analyst at Barclays
(1.35)
# 3,460
Out of 4,408 analysts
353
Total ratings
38.1%
Success rate
-0.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eliana Merle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBX MBX Biosciences | Maintained: Buy | $70 | $38.98 | +79.58% | 5 | Jun 15, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $157 | $68.00 | +130.88% | 18 | Jun 5, 2026 | |
| IVA Inventiva | Maintained: Buy | $18 | $3.76 | +378.72% | 4 | Jun 4, 2026 | |
| MRNA Moderna | Maintained: Hold | $48 | $52.13 | -7.92% | 27 | Jun 3, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | $59 | $28.55 | +106.65% | 8 | Jun 3, 2026 | |
| INSM Insmed | Maintained: Buy | $237 | $97.46 | +143.18% | 5 | May 28, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $120 | $76.77 | +56.31% | 10 | May 27, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $105 | $55.55 | +89.04% | 39 | May 21, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $917 | $614.98 | +49.11% | 3 | May 18, 2026 | |
| GOSS Gossamer Bio | Maintained: Sell | $0.3 → $0.28 | $0.167 | +67.66% | 13 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $73.92 | +55.57% | 18 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $12 | $7.07 | +69.73% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $2.64 | +657.58% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $20 | $15.77 | +26.82% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $342 → $345 | $223.29 | +54.51% | 11 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $964 | $498.66 | +93.32% | 13 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $527 | $287.80 | +83.11% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $607 → $615 | $450.46 | +36.53% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $25.31 | +69.93% | 5 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $27.87 | -10.30% | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $133 | $85.61 | +55.36% | 10 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $6.47 | +23.65% | 4 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $9.19 | +259.09% | 1 | Jan 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $115 → $117 | $90.80 | +28.85% | 25 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 → $20 | $59.51 | -66.39% | 25 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $96 → $112 | $124.30 | -9.90% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $63 → $12 | $77.15 | -84.45% | 3 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.67 | +380.48% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $21 | $7.49 | n/a | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $2.2 | $3.78 | n/a | 6 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 | $160.06 | n/a | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $5 | $34.06 | n/a | 3 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $18.09 | n/a | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $8.62 | n/a | 3 | Mar 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $192 → $134 | $28.62 | n/a | 10 | Aug 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $1.56 | n/a | 8 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.11 | n/a | 4 | Mar 18, 2019 |
MBX Biosciences
Jun 15, 2026
Maintained: Buy
Price Target: $70
Current: $38.98
Upside: +79.58%
BridgeBio Pharma
Jun 5, 2026
Maintained: Buy
Price Target: $157
Current: $68.00
Upside: +130.88%
Inventiva
Jun 4, 2026
Maintained: Buy
Price Target: $18
Current: $3.76
Upside: +378.72%
Moderna
Jun 3, 2026
Maintained: Hold
Price Target: $48
Current: $52.13
Upside: -7.92%
Tyra Biosciences
Jun 3, 2026
Maintained: Buy
Price Target: $59
Current: $28.55
Upside: +106.65%
Insmed
May 28, 2026
Maintained: Buy
Price Target: $237
Current: $97.46
Upside: +143.18%
PTC Therapeutics
May 27, 2026
Reiterated: Buy
Price Target: $120
Current: $76.77
Upside: +56.31%
BioMarin Pharmaceutical
May 21, 2026
Rated: Buy
Price Target: $105
Current: $55.55
Upside: +89.04%
Regeneron Pharmaceuticals
May 18, 2026
Maintained: Buy
Price Target: $917
Current: $614.98
Upside: +49.11%
Gossamer Bio
May 18, 2026
Maintained: Sell
Price Target: $0.3 → $0.28
Current: $0.167
Upside: +67.66%
May 15, 2026
Maintained: Buy
Price Target: $115
Current: $73.92
Upside: +55.57%
May 15, 2026
Maintained: Buy
Price Target: $37 → $12
Current: $7.07
Upside: +69.73%
May 14, 2026
Maintained: Buy
Price Target: $20
Current: $2.64
Upside: +657.58%
May 12, 2026
Rated: Hold
Price Target: $20
Current: $15.77
Upside: +26.82%
May 11, 2026
Rated: Buy
Price Target: $342 → $345
Current: $223.29
Upside: +54.51%
May 8, 2026
Rated: Buy
Price Target: $964
Current: $498.66
Upside: +93.32%
May 6, 2026
Maintained: Buy
Price Target: $527
Current: $287.80
Upside: +83.11%
May 6, 2026
Maintained: Buy
Price Target: $607 → $615
Current: $450.46
Upside: +36.53%
May 6, 2026
Maintained: Buy
Price Target: $43
Current: $25.31
Upside: +69.93%
May 6, 2026
Maintained: Hold
Price Target: $25
Current: $27.87
Upside: -10.30%
May 1, 2026
Maintained: Buy
Price Target: $133
Current: $85.61
Upside: +55.36%
Apr 2, 2026
Maintained: Hold
Price Target: $8
Current: $6.47
Upside: +23.65%
Jan 27, 2026
Maintained: Buy
Price Target: $33
Current: $9.19
Upside: +259.09%
Nov 6, 2025
Maintained: Hold
Price Target: $115 → $117
Current: $90.80
Upside: +28.85%
Aug 12, 2025
Maintained: Hold
Price Target: $33 → $20
Current: $59.51
Upside: -66.39%
Aug 8, 2025
Maintained: Hold
Price Target: $96 → $112
Current: $124.30
Upside: -9.90%
Jul 21, 2025
Downgraded: Hold
Price Target: $63 → $12
Current: $77.15
Upside: -84.45%
Jul 15, 2025
Maintained: Buy
Price Target: $8
Current: $1.67
Upside: +380.48%
May 15, 2025
Maintained: Buy
Price Target: $74 → $21
Current: $7.49
Upside: n/a
Jan 28, 2025
Maintained: Hold
Price Target: $5 → $2.2
Current: $3.78
Upside: n/a
Jan 8, 2025
Maintained: Buy
Price Target: $71
Current: $160.06
Upside: n/a
Apr 4, 2024
Maintained: Hold
Price Target: $3 → $5
Current: $34.06
Upside: n/a
Oct 13, 2022
Initiated Coverage: Buy
Price Target: $22
Current: $18.09
Upside: n/a
Mar 3, 2021
Reiterated: Buy
Price Target: $10
Current: $8.62
Upside: n/a
Aug 19, 2020
Maintained: Hold
Price Target: $192 → $134
Current: $28.62
Upside: n/a
Dec 11, 2019
Maintained: Buy
Price Target: $40
Current: $1.56
Upside: n/a
Mar 18, 2019
Reiterated: Buy
Price Target: $8
Current: $4.11
Upside: n/a